Detalhe da pesquisa
1.
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia.
Hematol Oncol
; 41(3): 520-534, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383121
2.
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.
Blood Cancer J
; 12(4): 61, 2022 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418180
3.
CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.
Front Immunol
; 12: 798087, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058934